The Financialization of Big Pharma

Authors

DOI:

https://doi.org/10.3989/ris.2020.78.4.m20.006

Keywords:

Corporate finance, Intangible assets, Monopoly, Shareholder value, Thorstein Veblen

Abstract


In this article, we employ a Veblenian framework to analyze three dimensions of corporate financialization: the expansion of the balance sheet, the rising importance of intangible assets and the growing levels of financial payouts. Our focus is the pharmaceutical sector, which is strongly dominated by a handful of large corporations known as Big Pharma. In our empirical analysis of the financial accounts of 27 of the largest global pharmaceutical corporations for the years 2000–2018, we find evidence of a shift in Big Pharma’s business model from one focused on productive capacity (reflected by fixed capital and R&D) to one focused on intangible assets (reflected by patents, brands and goodwill). The modus operandi of Big Pharma is one which increasingly resembles that of a private equity fund which generates returns for shareholders that are supported by monopolized knowledge through intellectual property rights, capitalized future earnings potential and rising debt burdens. Our framework facilitates the study of the different elements of financialization and how they do (or do not) co-evolve over time, within and between industries, and between countries or global regions.

Downloads

Download data is not yet available.

References

Aalbers, M. B. 2019. "Financialization". In The International Encyclopedia of Geography: People, the Earth, Environment, and Technology, edited by D. Richardson, N. Castree, M. F. Goodchild, A. Kobayashi, W. Liu, and R. A. Marston, 2nd ed. Oxford: Wiley.

Andersson, T., P. Gleadle, C. Haslam, and N. Tsitsianis. 2010. "Bio-Pharma: A Financialized Business Model". Critical Perspectives on Accounting 21 (7): 631-641. https://doi.org/10.1016/j.cpa.2010.06.006

Andersson, T., C. Haslam and E. Lee. 2006. "Financialized Accounts: Restructuring and Return on Capital Employed in the S&P 500". Accounting Forum 30 (1): 21-41. https://doi.org/10.1016/j.accfor.2006.01.001

Baranes, A. I. 2016. 'An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets'. PhD Thesis, Kansas City: University of Missouri.

Baranes, A. I. 2017. "Financialization in the American Pharmaceutical Industry: A Veblenian Approach". Journal of Economic Issues 51 (2): 351-358. https://doi.org/10.1080/00213624.2017.1320895

Baranes, A. I., and E. R. Hake. 2018. "The Institutionalist Theory of Capital in the Modern Business Enterprise: Appropriation and Financialization". Journal of Economic Issues 52 (2): 430-437. https://doi.org/10.1080/00213624.2018.1469895

Bates, T. W., K. M. Kahle, and R. M. Stulz. 2009. "Why Do U.S. Firms Hold So Much More Cash than They Used To?" The Journal of Finance 64 (5): 1985-2021. https://doi.org/10.1111/j.1540-6261.2009.01492.x

Bryan, D., M. Rafferty, and D. Wigan. 2017. "Capital Unchained: Finance, Intangible Assets and the Double Life of Capital in the Offshore World". Review of International Political Economy 24 (1): 56-86. https://doi.org/10.1080/09692290.2016.1262446

Christophers, B. 2019. "The Rentierization of the United Kingdom Economy". Environment and Planning A: Economy and Space, September, 0308518X1987300. https://doi.org/10.1177/0308518X19873007

Crotty, J. 2003. "The Neoliberal Paradox: The Impact of Destructive Product Market Competition and Impatient Finance on Nonfinancial Corporations in the Neoliberal Era". Review of Radical Political Economics 35 (3): 271-279. https://doi.org/10.1177/0486613403255533

Davis, L. E. 2016. "Identifying the "Financialization" of the Nonfinancial Corporation in the U.S. Economy: A Decomposition of Firm-Level Balance Sheets". Journal of Post Keynesian Economics 39 (1): 115-141. https://doi.org/10.1080/01603477.2015.1116370

Davis, L. E. 2018. "Financialization, Shareholder Orientation and the Cash Holdings of US Corporations". Review of Political Economy 30 (1): 1-27. https://doi.org/10.1080/09538259.2018.1429147

Durand, C. 2017. Fictitious Capital: How Finance Is Appropriating Our Future. London, New York: Verso.

Durand, C., and W. Milberg. 2020. "Intellectual monopoly in global value chains". Review of International Political Economy 27(2): 404-429. https://doi.org/10.1080/09692290.2019.1660703

Fernandez, R., P. Bortz, and N. Zeolla. 2018. "The Politics of Quantitative Easing. A Critical Assessment of the Harmful Impact of European Monetary Policy on Developing Countries". Amsterdam: SOMO. https://www.somo.nl/the-politics-of-quantitative-easing/

Fernandez, R., and R. Hendrikse. 2015. "Rich Corporations, Poor Societies: The Financialisation of Apple". Amsterdam: SOMO. https://www.somo.nl/wp-content/uploads/2015/10/Rich-corporations-poor-societies.pdf

Fiebiger, B. 2016. "Rethinking the Financialisation of Non-Financial Corporations: A Reappraisal of US Empirical Data". Review of Political Economy 28 (3): 354-379. https://doi.org/10.1080/09538259.2016.1147734

Froud, J., C. Haslam, S. Johal, and K. Williams. 2000. "Shareholder Value and Financialization: Consultancy Promises, Management Moves". Economy and Society 29 (1): 80-110. https://doi.org/10.1080/030851400360578

Froud, J., S. Johal, A. Leaver, and K. Williams, eds. 2006. Financialization and Strategy: Narrative and Numbers. London, New York: Routledge. https://doi.org/10.4324/9780203414941 PMCid:PMC1918052

Hofman, A., and M. B. Aalbers. 2019. A finance- and real estate-driven regime in the United Kingdom. Geoforum 100: 89-100. https://doi.org/10.1016/j.geoforum.2019.02.014

Hudson, M. 2015. Killing the Host. How Financial Parasites and Debt Bondage Destroy the Global Economy. Dresden: ISLET.

International Monetary Fund. 2006. World Economic Outlook April 2006. Globalization and Inflation. World Economic Outlook 2006, April. Washington, DC: International Monetary Fund.

International Monetary Fund. 2019. Global Financial Stability Report: Lower for Longer. Washington, DC: International Monetary Fund. https://www.imf.org/en/Publications/GFSR/Issues/2019/10/01/global-financial-stability-report-october-2019.

Ireland, P. 2009. "Financialization and Corporate Governance". Northern Ireland Legal Quarterly 60 (1): 1-34.

Jo, T.-H., and J. F. Henry. 2015. "The Business Enterprise in the Age of Money Manager Capitalism". Journal of Economic Issues 49 (1): 23-46. https://doi.org/10.1080/00213624.2015.1013877

Kaltenbrunner, A. 2018. "The Financialisation of Non-Financial Corporations in Brazil". In Debt Vulnerabilities in Developing Countries: A New Debt Trap? Volume I: Regional and Thematic Analyses, edited by UNCTAD, 53-71. New York, Geneva: United Nations. https://unctad.org/en/PublicationsLibrary/gdsmdp2017d4v1_en.pdf

Karwowski, E., and E. Stockhammer. 2017. "Financialisation in Emerging Economies: A Systematic Overview and Comparison with Anglo-Saxon Economies". Economic and Political Studies 5 (1): 60-86. https://doi.org/10.1080/20954816.2016.1274520

Kliman, A., and S. D. Williams. 2015. "Why "financialisation" Hasn't Depressed US Productive Investment". Cambridge Journal of Economics 39 (1): 67-92. https://doi.org/10.1093/cje/beu033

Krippner, G. R. 2005. "The Financialization of the American Economy". Socio-Economic Review 3 (2): 173-208. https://doi.org/10.1093/SER/mwi008

Lapavitsas, C. 2013. Profiting Without Producing. How Finance Exploits Us All. London, New York: Verso.

Lapavitsas, C., and J. Powell. 2013. "Financialisation Varied: A Comparative Analysis of Advanced Economies". Cambridge Journal of Regions, Economy and Society 6 (3): 359-379. https://doi.org/10.1093/cjres/rst019

Lazonick, W. 2013. "The Financialization of the U.S. Corporation: What Has Been Lost, and How It Can Be Regained". Seattle University Law Review 36 (2): 857-909.

Lazonick, W. 2014. "Profits Without Prosperity". Harvard Business Review, 1 September 2014. https://hbr. org/2014/09/profits-without-prosperity

Lazonick, W., and M. O'Sullivan. 2000. "Maximizing Shareholder Value: A New Ideology for Corporate Governance". Economy and Society 29 (1): 13-35. https://doi.org/10.1080/030851400360541

Lazonick, W, and Ö. Tulum. 2011. 'US Biopharmaceutical Finance and the Sustainability of the Biotech Business Model'. Research Policy 40 (9): 1170-1187. https://doi.org/10.1016/j.respol.2011.05.021

Leaver, A. 2018. "Intangible Concerns: Goodwill and the Risk of pro-Cyclicality in Corporate America". SPERI. 18 June 2018. http://speri.dept.shef.ac.uk/2018/06/19/intangible-concerns-goodwill-and-the-risk-of-pro-cyclicality-in-corporate-america/

Lee, R., G. L. Clark, J. Pollard, and A. Leyshon. 2009. "The Remit of Financial Geography - before and after the Crisis". Journal of Economic Geography 9 (5): 723-747. https://doi.org/10.1093/jeg/lbp035

Montalban, M., and M. E. Sakinç. 2013. "Financialization and Productive Models in the Pharmaceutical Industry". Industrial and Corporate Change 22 (4): 981-1030. https://doi.org/10.1093/icc/dtt023

Orhangazi, Ö. 2008. "Financialisation and Capital Accumulation in the Non-Financial Corporate Sector: A Theoretical and Empirical Investigation on the US Economy: 1973-2003". Cambridge Journal of Economics 32 (6): 863-886. https://doi.org/10.1093/cje/ben009

Orhangazi, Ö. 2018. "The Role of Intangible Assets in Explaining the Investment-Profit Puzzle". Cambridge Journal of Economics 43 (5): 1251-1286. https://doi.org/10.1093/cje/bey046

Perry, J., and A. Nölke. 2006. "The Political Economy of International Accounting Standards". Review of International Political Economy 13 (4): 559-86. https://doi.org/10.1080/09692290600839790

Rabinovich, J. 2019. "The Financialization of the Non-financial Corporation. A Critique to the Financial Turn of Accumulation Hypothesis". Metroeconomica, 70 (4): 738-775. https://doi.org/10.1111/meca.12251

Rikap, C. 2019. "Asymmetric Power of the Core: Technological Cooperation and Technological Competition in the Transnational Innovation Networks of Big Pharma". Review of International Political Economy 26 (5): 987-1021. https://doi.org/10.1080/09692290.2019.1620309

Serfati, C. 2008. "Financial Dimensions of Transnational Corporations, Global Value Chain and Technological Innovation". Journal of Innovation Economics 2 (2): 35-61. https://doi.org/10.3917/jie.002.0035

Serfati, C. 2011. "Transnational Corporations as Financial Groups". Work Organisation, Labour & Globalisation 5 (1): 10-38. https://doi.org/10.13169/workorgalaboglob.5.1.0010

Statista. 2019. "Global Pharmaceutical Industry". Dossier. https://www.statista.com/study/10642/global-pharmaceutical-industry-statista-dossier/

Stockhammer, E. 2004. "Financialisation and the Slowdown of Accumulation". Cambridge Journal of Economics 28 (5): 719-41. https://doi.org/10.1093/cje/beh032

Sweezy, P. M. 1958. "Veblen's Critique of the American Economy". The American Economic Review 48 (2): 21-29.

Tomaskovic-Devey, D., Ken-Hou L. and N. Meyers. 2015. "Did Financialization Reduce Economic Growth?" Socio-Economic Review 13 (3): 525-548. https://doi.org/10.1093/ser/mwv009

Tori, D., and Ö. Onaran. 2018a. "The Effects of Financialization on Investment: Evidence from Firm-Level Data for the UK". Cambridge Journal of Economics 42 (5): 1393-1416. https://doi.org/10.1093/cje/bex085

Tori, D., and Ö. Onaran. 2018b. "Financialization, Financial Development and Investment. Evidence from European Non-Financial Corporations". Socio-Economic Review, mwy044. https://doi.org/10.1093/ser/mwy044

UNCTAD. 2017. "Market Power and Inequality: The Revenge of the Rentiers". Pp. 119-145 in Trade and Development Report 2017. New York, Geneva: UN. https://doi.org/10.18356/584caae1-en

UNCTAD. 2018. "Corporate Rent-Seeking, Market Power and Inequality: Time for a Multilateral Trust Buster?" UNCTAD Policy Brief 66.

Veblen, T. 1908a. "On the Nature of Capital". The Quarterly Journal of Economics 22: 517-42. https://doi.org/10.2307/1884915

Veblen, T. 1908b. "On the Nature of Capital: Investment, Intangible Assets, and the Pecuniary Magnate". The Quarterly Journal of Economics 23: 104-136. https://doi.org/10.2307/1883967

Veblen, T. 1958 [1904]. The Theory of Business Enterprise. New York: Mentor.

Waller, W. T. 1982. "The Evolution of the Veblenian Dichotomy: Veblen, Hamilton, Ayres, and Foster". Journal of Economic Issues 16 (3): 757-771. https://doi.org/10.1080/00213624.1982.11504031

Zeller, Ch. 2007. "From the Gene to the Globe: Extracting Rents Based on Intellectual Property Monopolies". Review of International Political Economy 15 (1): 86-115. https://doi.org/10.1080/09692290701751316

Zwan, N. van der. 2014. "Making Sense of Financialization". Socio-Economic Review 12 (1): 99-129. https://doi.org/10.1093/ser/mwt020

Published

2020-12-15

How to Cite

Klinge, T. J. ., Fernandez, R. ., & Aalbers, M. B. . (2020). The Financialization of Big Pharma. Revista Internacional De Sociología, 78(4), e174. https://doi.org/10.3989/ris.2020.78.4.m20.006

Issue

Section

Articles